Development and evaluation of the Acromegaly Symptom Diary

Abstract Background Patient-reported outcome (PRO) measures are important to consider when evaluating treatments, yet there are no PRO measures for patients with acromegaly that have been developed in accordance with US Food and Drug Administration guidance. Acromegaly is a rare, chronic condition c...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Susan Martin, Randall H. Bender, Alan Krasner, Tonya Marmon, Michael Monahan, Lauren Nelson
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: SpringerOpen 2023-02-01
Cyfres:Journal of Patient-Reported Outcomes
Pynciau:
Mynediad Ar-lein:https://doi.org/10.1186/s41687-023-00541-7